AI

Delve into the world of AI in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on AI to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

The Comprehensive Department of China's National Medical Products Administration (NMPA) has released the Measures for the Implementation of Drug Market Exclusivity (Draft for Comment), proposing a unified exclusivity regime that…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.